-
9
-
-
35448957251
-
-
R. H. Baltz Microbe 2007 2 125 131
-
(2007)
Microbe
, vol.2
, pp. 125-131
-
-
Baltz, R.H.1
-
21
-
-
84870872119
-
-
GB 1458512, Gruppo Lepetit
-
C. Coronelli, F. Parenti, R. White and H. Pagani, GB 1458512, 1973, Gruppo Lepetit
-
(1973)
-
-
Coronelli, C.1
Parenti, F.2
White, R.3
Pagani, H.4
-
33
-
-
84870895106
-
-
WO 2005112990, Optimer Pharmaceuticals, Inc.
-
Y.-K. Shue, F. K. Babakhani, F. W. Okumu, P. S. Sears, S. L. Miller-Shangle and R. B. Walsh, WO 2005112990, 2005, Optimer Pharmaceuticals, Inc.
-
(2005)
-
-
Shue, Y.-K.1
Babakhani, F.K.2
Okumu, F.W.3
Sears, P.S.4
Miller-Shangle, S.L.5
Walsh, R.B.6
-
34
-
-
84870868378
-
-
WO 2006085838 A1, Optimer Pharmaceuticals, Inc.
-
Y.-K. Shue, C.-K. Hwang, Y.-H. Chiu, A. Romero, F. Babakhani, P. Sears and F. Okumu, WO 2006085838 A1, 2006, Optimer Pharmaceuticals, Inc.
-
(2006)
-
-
Shue, Y.-K.1
Hwang, C.-K.2
Chiu, Y.-H.3
Romero, A.4
Babakhani, F.5
Sears, P.6
Okumu, F.7
-
36
-
-
84870881024
-
-
US 5767096, Abbott Laboratories
-
J. E. Hochlowski, M. Jackson, J. B. McAlpine and R. R. Rasmussen, US 5767096, 1998, Abbott Laboratories
-
(1998)
-
-
Hochlowski, J.E.1
Jackson, M.2
McAlpine, J.B.3
Rasmussen, R.R.4
-
37
-
-
84870932164
-
-
WO 2007048059 A2, Optimer Pharmaceuticals, Inc.
-
P. Sears, Y.-K. Shue, S. L. Miller-Shangle, R. B. Walsh, F. Babakhani, Y.-H. Chiu, A. Romero, S. Gorbach and T. J. Louie, WO 2007048059 A2, 2007, Optimer Pharmaceuticals, Inc.
-
(2007)
-
-
Sears, P.1
Shue, Y.-K.2
Miller-Shangle, S.L.3
Walsh, R.B.4
Babakhani, F.5
Chiu, Y.-H.6
Romero, A.7
Gorbach, S.8
Louie, T.J.9
-
38
-
-
84870881501
-
-
US 20070105791, Optimer Pharmaceuticals, Inc.
-
P. Sears, S. L. Miller-Shangle, R. B. Walsh, Y.-K. Shue, F. Babakhani, T. J. Louie, Y.-H. Chiu, A. Romero and S. Gorbach, US 20070105791, 2007, Optimer Pharmaceuticals, Inc.
-
(2007)
-
-
Sears, P.1
Miller-Shangle, S.L.2
Walsh, R.B.3
Shue, Y.-K.4
Babakhani, F.5
Louie, T.J.6
Chiu, Y.-H.7
Romero, A.8
Gorbach, S.9
-
39
-
-
84870902156
-
-
US 20080176927 A1, Optimer Pharmaceuticals, Inc.
-
S. Sanghvi, M. Roach, J. F. Zhou, E. M. Mittleberg and P. He, US 20080176927 A1, 2008, Optimer Pharmaceuticals, Inc.
-
(2008)
-
-
Sanghvi, S.1
Roach, M.2
Zhou, J.F.3
Mittleberg, E.M.4
He, P.5
-
40
-
-
79851495866
-
-
Y. Xiao S. Li S. Niu L. Ma G. Zhang H. Zhang G. Zhang J. Ju C. Zhang J. Am. Chem. Soc. 2011 133 1092 1105
-
(2011)
J. Am. Chem. Soc.
, vol.133
, pp. 1092-1105
-
-
Xiao, Y.1
Li, S.2
Niu, S.3
Ma, L.4
Zhang, G.5
Zhang, H.6
Zhang, G.7
Ju, J.8
Zhang, C.9
-
41
-
-
79960476383
-
-
S. Nui T. Hu S. Li Y. Xiao L. Ma G. Zhang H. Zhang X. Yang J. Ju C. Zhang ChemBioChem 2011 12 1740 1748
-
(2011)
ChemBioChem
, vol.12
, pp. 1740-1748
-
-
Nui, S.1
Hu, T.2
Li, S.3
Xiao, Y.4
Ma, L.5
Zhang, G.6
Zhang, H.7
Yang, X.8
Ju, J.9
Zhang, C.10
-
42
-
-
84870878769
-
-
Patent CN 2010-10592416
-
C. Zhang, Y. Xiao, S. Li, S. Niu, G. Zhang, H. Zhang, T. Hu and J. Ju, Patent CN 2010-10592416, 2011
-
(2011)
-
-
Zhang, C.1
Xiao, Y.2
Li, S.3
Niu, S.4
Zhang, G.5
Zhang, H.6
Hu, T.7
Ju, J.8
-
43
-
-
84870930825
-
-
Patent CN 2010-10526416
-
C. Zhang, S. Li, Y. Xiao, S. Niu and J. Ju, Patent CN 2010-10526416, 2011
-
(2011)
-
-
Zhang, C.1
Li, S.2
Xiao, Y.3
Niu, S.4
Ju, J.5
-
44
-
-
84870926734
-
-
CN 102115757, Faming Zhuanli Shenqing
-
C. Zhang, Y. Xiao, L. Sumei, S. Niu, G. Zhang, H. Zhang, T. Hu and J. Ju, CN 102115757, 2011, Faming Zhuanli Shenqing
-
(2011)
-
-
Zhang, C.1
Xiao, Y.2
Sumei, L.3
Niu, S.4
Zhang, G.5
Zhang, H.6
Hu, T.7
Ju, J.8
-
45
-
-
84870926624
-
-
WO 2004014295 A2, Optimer Pharmaceuticals, Inc.
-
Y.-K. Shue, C.-J. F. Du, M.-H. Chiou, M.-C. Wu, Y.-T. Chen, F. W. Okumu and J. J. Duffield, WO 2004014295 A2, 2004, Optimer Pharmaceuticals, Inc.
-
(2004)
-
-
Shue, Y.-K.1
Du, C.-J.F.2
Chiou, M.-H.3
Wu, M.-C.4
Chen, Y.-T.5
Okumu, F.W.6
Duffield, J.J.7
-
46
-
-
52949083239
-
-
M. Kurabachew S. H. J. Lu P. Krastel E. K. Schmitt B. L. Suresh A. Goh J. E. Knox N. L. Ma J. Jiricek D. Beer M. Cynamon F. Petersen V. Dartois T. Keller T. Dick V. K. Sambandamurthy J. Antimicrob. Chemother. 2008 62 713 719
-
(2008)
J. Antimicrob. Chemother.
, vol.62
, pp. 713-719
-
-
Kurabachew, M.1
Lu, S.H.J.2
Krastel, P.3
Schmitt, E.K.4
Suresh, B.L.5
Goh, A.6
Knox, J.E.7
Ma, N.L.8
Jiricek, J.9
Beer, D.10
Cynamon, M.11
Petersen, F.12
Dartois, V.13
Keller, T.14
Dick, T.15
Sambandamurthy, V.K.16
-
54
-
-
84870933213
-
-
WO 2006085838 A1, Optimer Pharmaceuticals, Inc.
-
Y.-K. Shue, C.-K. Hwang, Y.-H. Chiu, A. Romero, F. Babakhani, P. Sears and F. Okumu, WO 2006085838 A1, 2006, Optimer Pharmaceuticals, Inc.
-
(2006)
-
-
Shue, Y.-K.1
Hwang, C.-K.2
Chiu, Y.-H.3
Romero, A.4
Babakhani, F.5
Sears, P.6
Okumu, F.7
-
55
-
-
84870902368
-
-
US 20090110718 A1, Echem Hightech Co. Ltd
-
M.-C. Wu, C.-C. Huang, Y.-C. Lu and W.-J. Fan, US 20090110718 A1, 2009, Echem Hightech Co. Ltd
-
(2009)
-
-
Wu, M.-C.1
Huang, C.-C.2
Lu, Y.-C.3
Fan, W.-J.4
-
72
-
-
42049099454
-
-
Y. K. Shue P. S. Sears S. Shangle R. B. Walsh C. Lee S. L. Gorbach F. Okumu R. A. Preston Antimicrob. Agents Chemother. 2008 52 1391 1395
-
(2008)
Antimicrob. Agents Chemother.
, vol.52
, pp. 1391-1395
-
-
Shue, Y.K.1
Sears, P.S.2
Shangle, S.3
Walsh, R.B.4
Lee, C.5
Gorbach, S.L.6
Okumu, F.7
Preston, R.A.8
-
75
-
-
84870912887
-
-
News and analysis in, 260 For a systematic review on the comparative effectiveness of C. difficile treatments, see
-
News and analysis in Nature Rev. Drug Discovery, 2010, 9, 260
-
(2010)
Nature Rev. Drug Discovery
, vol.9
-
-
-
81
-
-
78049517194
-
-
G. W. Tannock K. Munro C. Taylor B. Lawley W. Young B. Byrne J. Emery T. Louie Microbiology 2010 156 3354 3359
-
(2010)
Microbiology
, vol.156
, pp. 3354-3359
-
-
Tannock, G.W.1
Munro, K.2
Taylor, C.3
Lawley, B.4
Young, W.5
Byrne, B.6
Emery, J.7
Louie, T.8
-
93
-
-
80053908350
-
-
references therein
-
A. Srivastava M. Talaue S. Liu D. Degen R. Y. Ebright E. Sineva A. Chakraborty S. Y. Druzhinin S. Chatterjee J. Mukhopadhyay Y. W. Ebright A. Zozula J. Shen S. Sengupta R. R. Niedfeldt C. Xin T. Kaneko H. Irschik R. Jansen S. Donadio N. Connell R. H. Ebright Curr. Opin. Microbiol. 2011 14 532 543
-
(2011)
Curr. Opin. Microbiol.
, vol.14
, pp. 532-543
-
-
Srivastava, A.1
Talaue, M.2
Liu, S.3
Degen, D.4
Ebright, R.Y.5
Sineva, E.6
Chakraborty, A.7
Druzhinin, S.Y.8
Chatterjee, S.9
Mukhopadhyay, J.10
Ebright, Y.W.11
Zozula, A.12
Shen, J.13
Sengupta, S.14
Niedfeldt, R.R.15
Xin, C.16
Kaneko, T.17
Irschik, H.18
Jansen, R.19
Donadio, S.20
Connell, N.21
Ebright, R.H.22
more..
-
95
-
-
84870913209
-
-
WO 9635702 A1, Abbott Laboratories
-
J. B. McAlpine and J. E. Hochlowski, WO 9635702 A1, 1996, Abbott Laboratories
-
(1996)
-
-
McAlpine, J.B.1
Hochlowski, J.E.2
-
96
-
-
84870876346
-
-
WO 2009070779 A1, Optimer Pharmaceuticals, Inc.
-
Y. Ichikawa, Y.-H. Chiu, Y.-K. Shue and F. K. Babakhani, WO 2009070779 A1, 2009, Optimer Pharmaceuticals, Inc.
-
(2009)
-
-
Ichikawa, Y.1
Chiu, Y.-H.2
Shue, Y.-K.3
Babakhani, F.K.4
-
97
-
-
84870934303
-
-
US 20080269145 A1, Optimer Pharmaceuticals, Inc.
-
Y.-K. Shue, C.-K. Hwang, Y.-H. Chiu, A. Romero, F. Babakhani, P. Sears and F. Okumu, US 20080269145 A1, 2008, Optimer Pharmaceuticals, Inc.
-
(2008)
-
-
Shue, Y.-K.1
Hwang, C.-K.2
Chiu, Y.-H.3
Romero, A.4
Babakhani, F.5
Sears, P.6
Okumu, F.7
-
98
-
-
84870953939
-
-
US 20100008825 A1, Optimer Pharmaceuticals, Inc.
-
Y.-K. Shue, C.-K. Hwang, Y.-H. Chiu, A. Romero, F. Babakhani, P. Sears and F. Okumu, US 20100008825 A1, 2010, Optimer Pharmaceuticals, Inc.
-
(2010)
-
-
Shue, Y.-K.1
Hwang, C.-K.2
Chiu, Y.-H.3
Romero, A.4
Babakhani, F.5
Sears, P.6
Okumu, F.7
-
105
-
-
84870938313
-
-
US 2938900, Merck & Co.
-
E. Walton, US 2938900, 1960, Merck & Co.
-
(1960)
-
-
Walton, E.1
-
112
-
-
80051957059
-
-
erratum: Clin. Infect. Dis., 2011, 53, 1312
-
K. M. Mullane M. A. Miller K. Weiss A. Lentnek Y. Golan P. S. Sears Y.-K. Shue T. J. Louie S. L. Gorbach Clin. Infect. Dis. 2011 53 440 447
-
(2011)
Clin. Infect. Dis.
, vol.53
, pp. 440-447
-
-
Mullane, K.M.1
Miller, M.A.2
Weiss, K.3
Lentnek, A.4
Golan, Y.5
Sears, P.S.6
Shue, Y.-K.7
Louie, T.J.8
Gorbach, S.L.9
-
115
-
-
79551527297
-
-
T. J. Louie M. A. Miller K. M. Mullane K. Weiss A. Lentnek Y. Golan S. Gorbach P. Sears Y.-K. Shue N. Engl. J. Med. 2011 364 422 431
-
(2011)
N. Engl. J. Med.
, vol.364
, pp. 422-431
-
-
Louie, T.J.1
Miller, M.A.2
Mullane, K.M.3
Weiss, K.4
Lentnek, A.5
Golan, Y.6
Gorbach, S.7
Sears, P.8
Shue, Y.-K.9
-
116
-
-
84859007390
-
-
O. A. Cornely D. W. Crook R. Esposito A. Poirier M. S. Somero K. Weiss P. Sears S. Gorbach Lancet Infect. Dis. 2012 1 281 289
-
(2012)
Lancet Infect. Dis.
, vol.1
, pp. 281-289
-
-
Cornely, O.A.1
Crook, D.W.2
Esposito, R.3
Poirier, A.4
Somero, M.S.5
Weiss, K.6
Sears, P.7
Gorbach, S.8
-
117
-
-
84863686440
-
-
D. W. Crook A. S. Walker Y. Kean K. Weiss O. A. Cornely M. A. Miller R. Esposito T. J. Louie N. E. Stoesser B. C. Young B. J. Angus S. L. Gorbach T. E. A. Peto Clin. Infect. Dis. 2012 55 Suppl 2 S93 S103
-
(2012)
Clin. Infect. Dis.
, vol.55
, Issue.SUPPL. 2
-
-
Crook, D.W.1
Walker, A.S.2
Kean, Y.3
Weiss, K.4
Cornely, O.A.5
Miller, M.A.6
Esposito, R.7
Louie, T.J.8
Stoesser, N.E.9
Young, B.C.10
Angus, B.J.11
Gorbach, S.L.12
Peto, T.E.A.13
-
119
-
-
84943009700
-
-
http://www.fda.gov/NewsEvents/Newsroom/PressAnnouncements/ucm257024.htm
-
-
-
-
121
-
-
84870903848
-
-
News in, 37-45
-
News in Drugs, 2010, 10, 37-45
-
(2010)
Drugs
, vol.10
-
-
|